L. Arrigoni

Leadless pacemaker - state of art and incoming developments to broaden indications.

A. Curnis, F. Salghetti, D. Fabbricatore, 2020, Pacing and clinical electrophysiology : PACE.

Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy.

A. Colombo, M. Taramasso, F. Maisano, 2018, International journal of cardiology.

Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus.

R. Fattori, A. Colombo, C. Briguori, 2017, International journal of cardiology.

Prognostic impact of the updated 2018 HFA‐ESC definition of advanced heart failure: results from the HELP‐HF registry

M. Metra, M. Chiarito, G. Sinagra, 2022, European journal of heart failure.

Real-world 2-year outcome of atrial fibrillation treatment with dabigatran, apixaban, and rivaroxaban in patients with and without chronic kidney disease

A. Colombo, A. Margonato, P. Della Bella, 2019, Internal and Emergency Medicine.

Cardiac conduction defects

V. Precone, P. Chiurazzi, M. Bertelli, 2019, Acta bio-medica : Atenei Parmensis.

Availability of synthetic salmon calcitonin in tissue fluid after a single intravenous dose

E. Concia, M. Cruciani, L. Arrigoni, 2004, European Journal of Clinical Pharmacology.